IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
Publication date:
2015
Publisher version:
Citación:
British Journal of Cancer, 112(7), p. 1190-1198 (2015); doi:10.1038/bjc.2015.64
Descripción física:
p. 1190-1198
ISSN:
DOI:
Patrocinado por:
This study was funded by GlaxoSmithKline. Pfizer provided funding for the Spanish Oncology Genitourinary Group (SOGUG) sunitinib study.
Files in this item
Métricas
Compartir
Estadísticas de uso
Metadata
This item is protected with a Creative Commons License